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1. Introduction 
Myeloperoxidase @IPO) is an unusual and com- 
plex heme-containing glycoprotein [ 1,2] which plays 
an important functional role in the oxidative metab- 
olism of PMN from many sources [3]. The isolation 
and purification of this enzyme [l] has been described 
and fluorochrome-labeled antibodies made against 
highly purified human MPO have been useful in 
studies aimed at elucidating the role of MPO-contain- 
ing azurophilic granules in phagocytosis by PMN [4]. 
However, there appear to be multiple forms of MPO 
which have different properties [5-81. Polyacryl- 
amide gel electrophoresis data in [5,7] support the 
idea that human MPO consists of a number of isoen- 
zymes. Often, the genetic origin of the forms was not 
clear because PMN had been pooled from many 
donors. 
enzyme treatment [lo]. However, according to [ 1 l] 
many commonly used procedures for preventing pro- 
teolysis, such as use of PMSF and divalent cation 
chelators, are not effective in the isolation of intact 
proteins from human PMN; only the use of DFP pre- 
vented proteolysis [ 111. 
Here, we present evidence that MPO from a single 
human donor can be resolved into 3 distinct chro- 
matographic species which are native to PMN, which 
have the same Mr-values, but which exhibit different 
sensitivities to inhibition by AT. This is the first 
description of a chromatographic procedure for the 
preparative and reproducible isolation of these differ- 
ent forms of MPO from normal, human PMN. Further 
studies on the biochemical and functional characteri- 
zation of these enzymes should now be possible. 
PMN are an unusually rich source of proteolytic 
enzymes [9]; multiple forms of MPO may be degra- 
dative artifacts of the isolation procedure. MPO 
appears to be resistant to trypsin as shown by similar- 
ities in gel electrophoresis patterns before and after 
2. Materials and methods 
Abbreviations: MPO, myeloperoxidase; PMN, polymorpho- 
nuclear leukocyte; PMSF, phenylmethylsulfonylfluoride; 
DFP, diisopropylfluorophosphate; AT, S-amino-l ,2,4-triazole; 
TPCK, L-l-tosylamide-2phenylethylchloromethyl ketone; 
CETAB, cetyltrimethylammonium bromide;M,, relative 
molecular mass 
PMSF, TPCK, DFP, guaiacol and AT were obtained 
from Sigma (St Louis MO). FicollHypaque (lympho- 
cyte separation medium) was obtained from Litton 
Bionetics (Kensington MD). CETAB was from Eastman 
Kodak (Rochester NY). All other chemicals were of 
reagent grade purity. 
2.1. Cells 
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Human PMN were obtained from healthy male and 
female donors undergoing leukapheresis or by routine 
collection of peripheral blood in heparinized tubes. 
PMN were further purified by hypotonic lysis of 
residual red blood cells [ 121 followed by sedimenta- 
tion through Ficoll-Hypaque [ 131. Peripheral red 
blood cells were sedimented using dextran [ 131, and 
PMN were further purified as above. The human 
acute promyelocytic leukemia cell line @IL-60) was 
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obtained from Dr R. C. Gallo (National Cancer Insti- 
tute) and was maintained in liquid suspension culture 
as in [14]. 
2.2. Extraction procedures 
To prepare granules, PMN were suspended at 2.5 X 
10’ cells/ml in ice-cold 0.34 M sucrose containing 
10 ,ng/ml each of PMSF and TPCK and 1 mM EDTA. 
In some preparations, PMN were also treated with 
DFP as in [ Ill. Homogenates were made using a 
motor-driven Teflon-glass homogenizer (900 rev./ 
min, 5 min) followed by centrifugation at 500 X g 
for 5 min at 4’C. The supernatants were collected 
and the pellets containing unbroken cells, nuclei and 
membranes were rehomogenized, centrifuged and the 
supernatants pooled. This process was continued 
(usually l-2 times) until the pellets lost most of their 
green color. The pooled supernatants were centrifuged 
at 27 000 X g for 15 min (4’C) to pellet granules 
which were used fresh or stored frozen at -2O’C. 
Granules were solubilized by a slight modification 
of the method in [ 151. Granules were suspended in 
ice-cold 0.2 M sodium acetate buffer containing 1 M 
NaCl, 10 E.tg/ml each of PMSF, TPCK and 1 mM 
EDTA (pH 4.7)and homogenized as above for 2-4 min. 
Solubilized MPG was recovered in the supernatant 
after centrifugation at 27 000 X g for 10 min (4’C). 
The procedure was repeated until MPO was essentially 
undetectable in the supernatants (l-2 extractions). 
The MPG containing extract was dialyzed against 
25 mM sodium acetate buffer containing 0.1 M NaCl 
(pH 4.7) and the precipitate which formed was 
removed by centrifugation at 27 000 X g for 15 min. 
MPG remaining in the pellet was removed by dispers- 
ing the pellet in 25 mM sodium acetate buffer con- 
taining 0.5 M NaCl (pH 4.7) and recentrifuged as 
above. MPG was also solubilized from granules pre- 
pared and extracted as in [ 161 (kindly supplied by 
Professor J. K. Spitznagel, Dept. Microbiology and 
Immunology). Alternatively, MPO was extracted 
from whole PMN by suspending the cells (2 X 10’1 
ml) in an ice-cold lysing medium (0.3% CETAB in 
10 mM sodium phosphate buffer (pH 7.0)) for 30- 
45 min [ 171. Detergent lysates were then centrifuged 
at 27 000 X g for 15 min and solubilized MPO was 
recovered in the supernatant. 
2.3. Chromatography and immunodif$sion 
All chromatography was performed at 4’C. CETAB 
lysates of whole PMN were made 0.2 M NaCl and 
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applied directly to a column of carboxymethyl-cel- 
lulose (CM-52, 1.6 X 23 cm) equilibrated in 25 mM 
sodium acetate buffer containing 0.2 M NaCl (pH 4.7). 
Alternatively, extracts were first dialyzed against the 
equilibration buffer prior to application to the col- 
umn. Protein was followed at 280 nm using a flow- 
through absorbance monitor. After protein in column 
effluents had returned to baseline, a linear 800 ml salt 
gradient was used to elute the enzyme (0.2-I .O M 
NaCl). A flowrate of 10 ml/h was maintained. In 
some experiments, granule extracts containing rela- 
tively small amounts of activity (50-200 units) 
were chromatographed on a smaller column (0.9 X 
20 cm, 250 ml salt gradient) using a flow rate of 
5 ml/h. Identical elution profiles were obtained with 
columns of either size. 
Gel filtration chromatography using Sephadex 
G-l 50 (superfine) was done as in [2] except that the 
column dimensions were 16 X 90 cm and the experi- 
ment was performed at 4’C. For determination of 
Mr-values, the column was calibrated with the follow- 
ing standards (M,): blue dextran (V,); cytochrome c 
(12 400); lysozyme (14 400); horseradish peroxidase 
(44 050); conalbumin (86 180). 
Double immunodiffusion was performed in 1% 
agarose, 10 mM sodium phosphate buffer containing 
1 .O M NaCl (pH 7 .O) overnight in a humid chamber. 
Proteins not precipitated were washed out with 
0.15 M NaCl. The gels were then stained for protein 
(amid0 black) or enzyme activity (diaminobenzidine). 
2.4, Polyacrylamide gel electrophoresis 
Native slab gel electrophoresis (7.5% acrylamide) 
was done as in [23] without the use of a stacking gel. 
Gels were preelectrophoresed for 45 min and were 
stained for protein (12 h) using Coomassie brilliant 
blue R-250 (1.8 g/l) in 25% methanol, 10% acetic 
acid. Destaining was carried out in 25% ethanol, 10% 
acetic acid. Peroxidase activity was visualized by 
incubating the gel (25’C) in a solution of diamino- 
benzidine (0.4 mg/ml) in 10 mM sodium phosphate 
buffer (pH 7 .O) containing 1 mM HaOa. RF -Values 
were calculated as the ratio of the distance the pro- 
tein migrated to that of the dye front (methyl green). 
2.5. Assay of MPO 
MPG was assayed by measuring the formation of 
tetraguaiacol at 470 nm as in [8]. One unit was 
defined as that amount of enzyme catalyzing a change 
of 1 .O absorbance unit/mm 
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3. Results 
3 .l . Isolation and fractionation of MPO 
When a CETAB extract of whole PMN was subjected 
to ion-exchange chromatography on carboxymethyl- 
cellulose, the typical elution profile in fig.lA was 
obtained. Three peaks of MPO activity, designated I, 
II and III, were routinely resolved, eluting at -0.36 M, 
0.42 M and 0.48 M NaCl, respectively. 
To investigate whether these 3 peaks of activity 
represented different native forms of MPO or were 
perhaps artifacts resulting from proteolytic degrada- 
tion during isolation, the enzyme was isolated using 
several different procedures. These included: 
(i) Direct extraction of whole PMN at pH 7.0 in the 
presence of the cationic detergent CETAB as in 
c171; 
(ii) Extraction of PMN granules at pH 7.0 in the 
presence of CETAB; 
(iii) Extraction of PMN granules with 0.2 M sodium 
acetate buffer (pH 4.0) as in [ 161; 
(iv) Extraction of PMN granules with 0.2 M sodium 
acetate buffer containing 1 M NaCl (pH 4.7) a 
slight modification of the procedure in [ 151. 
In all cases, MPO peaks II and III were observed fol- 
lowing ionexchange chromatography such as 
Effluent volume (ml) 
Fig.1. Ionexchange chromatography of normal human MPO 
from CETAB extracted PMN (A) and salt extracted PMN 
granules (B). Extracts were prepared as in section 2. The 
carboxymethyl-cellulose (CM-5 2,1.6 X 23 cm) was equili- 
brated with 0.025 M sodium acetate buffer containing 0.2 M 
Nail (pH 4.7). After applying the sample (800-1000 units 
MPO), the column was washed with equilibration buffer 
until the&,, returned to baseline at which time the linear 
salt gradient was started (0.2-1.0 M, 800 ml total vol.). The 
flow rate was 10 ml/h and 2 ml fractions were collected. 
(@-e) MPO activity; ( . . . )Azso; (o---o) NaCl gradient. 
Arrow indicates start of gradient. 
described in fig.1, while the amount of peak I was 
variable, depending on the extraction procedure 
employed (see section 3.2). 
Use of whole celI extracts often resulted in poorer 
resolution of the 3 peaks of MPO activity as com- 
pared to granule preparations. This was especially 
true when equivalent amounts of protein were loaded 
onto the ion-exchange column. Most likely, this was 
due to association of the highly cationic MPO [ 181 
with other anionic species present in whole cell 
lysates. For example, it was necessary to include 1 M 
NaCl in agar double immunodiffusion gels of MPO to 
counter such non-specific interactions [ 121. 
All 3 peaks of MPO activity eluted at their charac- 
teristic salt concentrations when subjected to rechro- 
matography under identical conditions on the same 
ion-exchange column. In addition, rechromatography 
of the poorly resolved peaks resulting from fractiona- 
tion of certain whole cell lysates yielded peaks I-III. 
Furthermore, these same 3 peaks were observed 
whether or not a mixed or homogenous buffer system 
was employed, i .e . , loading of the sample in sodium 
phosphate buffer (pH 7.0) onto the column equilibrated 
with sodium acetate buffer (pH 4.7) gave the same 
elution profile as when the sample was first dialyzed 
overnight against the pH 4.7 equilibration buffer. 
These results indicated that the 3 peaks of MPO activ- 
ity were not due to an artifact of the chromatographic 
procedure. 
3.2. Variation in the relative proportion of activities 
Although different isolation procedures consistently 
revealed the presence of 3 MPO activities, the relative 
proportions varied, especially the amount of peak I. 
The chromatographic profile in fig.lB was obtained 
when a sample of salt extracted PMN granules, pre- 
pared as in [ 161 (kindly supplied by Professor 
Spitznagel) was chromatographed using our standard 
conditions. It can be seen that all 3 peaks of MPO 
activity were present, but that peak I was consider- 
ably reduced in amount. Further studies have shown 
that complete extraction of peak I required the use 
of CETAB, while peaks II and III were completely 
extracted by salt solutions in the absence of a deter- 
gent. Moreover, when PMN are pretreated with cyto- 
chalasin B and subsequently challenged with a chemo- 
tactic factor, there is a preferential degranulation of 
only MPO peaks II and III. These results, including 
the purification and properties of peaks I-III, will be 
fully described elsewhere [ 191. 
105 
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3.3. Use of pro tease inhibitors 
Many of the proteolytic enzymes associated with 
PMN such as elastase-like nzymes, collagenase and 
cathepsinC have optimum activities around neutral 
pH [9]. Use of acid extraction procedures is designed 
to minimize degradation by these neutral proteases. 
However, the fact that MPG peaks I-III were observed 
whether isolation utilized whole cells or granules 
extracted at pH 4.0 or pH 7.0 indicated that these 
different activities did not result from random pro- 
teolytic degradation. To further test this idea, MPO 
was isolated in the combined presence of 3 protease 
inhibitors which have been utilized-with PMN: EDTA 
(1 mM) and PMSF and TPCK (10 pg/ml each) [ 1 I]. 
The same results as in fig.1 were obtained whether or 
not these inhibitors were present during the isolation 
procedure. In addition, preincubation of the ceils 
with 5 mM DFP [ 1 l] prior to extraction or prepara- 
tion of the granules did not reduce the complexity of 
the chromatographic profile of MPO activities. 
3.4. Mr- Values and native gel electrophoresis 
The app. MI of each of the 3 different peaks of 
MPG activity was determined from its respective elu- 
tion volume using a calibrated Sephadex G-l 50 col- 
umn. No significant differences were observed between 
any of the 3 MPG activities, and the calculated Mr of 
89 000 agreed well with the Mr of 88 000 for highly 
purified human MPG [2]. When non-denaturing poly- 
acrylamide gel electrophoresis was performed on each 
of the different MPO activities, no significant differ- 
ences were observed in their mobilities. There was an 
exact correspondence between the single band visu- 
alized by the activity stain in each of the MPO samples. 
Furthermore, the mobility of these different MPG 
species (RF 0.25,7.5% acrylamide) was comparable 
to that reported for MPG purified from human PMN 
([2], RF 0.24,6% acrylamide). 
3.5. Differential sensitivity to A T 
MPG derived from elicited murine peritoneal 
exudate cells could be resolved into 2 chromatographic 
forms exhibiting different sensitivity to inhibition by 
AT [8]. Thus, it was of interest to examine the sensi- 
tivity of the 3 forms of human MPG activity to this 
inhibitor. The data in table 1 show that the activity 
associated with peak I was most sensitive to inhibi- 
tion while the activity associated with peak III was 
the least sensitive. Moreover, the differences in inhibi- 
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Table 1 
Inhibition (%) of peroxidase activity by 3amlno-1,2,4-triazole 
(AT) 
Chromatographic [ATI bWb 
forma 1 2 5 10 20 40 
I 23 33 41 55 63 81 
II 3 10 41 50 63 80 
III 2 8 24 34 51 19 
a Equivalent amounts of peroxidase activity were compared 
for each chromatographic form (0.31-0.38 gualacol units) 
(see tIg.1) 
b AT was mixed directly with the reaction mixture prior to 
the start of the reaction 
Values represent he mean of duplicate determinations and 
are expressed as % of the untreated control; range of the 
values was <5% of the mean 
tion were most pronounced at lower concentrations 
of AT (I 10 mM). 
3.6. Reaction with antibody 
The immunological cross-reactivity of the differ- 
ent forms of MPG from normal human PMN was 
tested using a rabbit antibody (generously provided 
by Professor Spitznagel) prepared against highly puri- 
fied human MPG [ 161. Fig.2 shows that all 3 peaks 
Fig.2. A double immunodiffusion gel of the different chro- 
matographic forms of normal human MPO and MPO from 
human leukemic HL-60 cells (details in section 2); Ab, rabbit 
anti-human MPO;N, normal PMN lysate; L, HL-60 cell lysate; 
I, II, III refer to the MPO peaks described in fig.1. 
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reacted with one another to give a single line of iden- 
tity in Ouchterlony double diffusion gels. In addition, 
unfractionated MPO in normar -hole PMN lysates 
and from a line of human acute promyelocytic leuke- 
mia cells (I-IL-60), as well as the purified MPO antigen 
(not shown), all reacted with the antibody to give a 
single line of identity. 
4. Discussion 
These data support he conclusion that normal 
human PMN contain 3 distinct chromatographic 
forms of MPO. The use of different isolation proce- 
dures, including whole cells, granules, extractions at 
different pH values, with and without detergents 
and/or protease inhibitors, all gave the same 3 peaks 
of MPO activity. The fact that MPO peak I apparently 
required the use of detergent to effect its extraction, 
while peaks II and III were extracted without the use 
of detergent suggests hat there may be differences 
in the compartmentalization f the different forms of 
this enzyme within the PMN, perhaps in different 
granules [ 191. These 3 different forms of MPO appear 
to be native to the PMN rather than artifacts of the 
isolation procedure. 
When homogenous preparations of MPO, prepared 
as in [ 15 ,161, were subjected to chromatography as
described here, multiple peaks were observed. In addi- 
tion, there were no significant differences in the 
M,-values, of the 3 MPO activities (89 000); this 
being essentially identical to the anomalously ow 
Mr of 88 000 reported for purified human MPO [2] 
when measured using the same gel filtration condi- 
tions. Moreover, the 3 different MPO activities had 
essentially the same mobility when subjected to 
native polyacrylamide gel electrophoresis; migration 
was similar to hat for purified human MPO run 
under similar conditions [2]. That these 3 forms were 
also observed in cells from a single donor indicated 
that such heterogeneity was not he result of genetic 
diversity arising from multiple donors. 
HL-60 cells, a line of human acute promyelocytic 
leukemia cells, contain multiple forms ofMP0 [20, 
2 I]. One of the forms was smaller in MI, and there 
were differences in the relative proportions of the 
large and small forms in more mature, differentiated 
cells as compared to the relatively undifferentiated, 
immature cells [20]. Normal, mature peripheral blood 
PMN contained only the large form of MPO. MPO 
binds to concanavalin A-Sepharose [21,22] and dif- 
ferential elution of one of the large forms of MPO 
suggested that the heterogeneity was partly due to 
differences in sugar moieties [21]. Although the 
small and large forms of MPO from HL-60 cells could 
not be distinguished by Ouchterlony double immuno- 
diffusion, a difference was observed using a micro- 
complement fixation test [2 11. Our data are consis- 
tent with these observations, and indicated that the 
multiple forms of MPO from normal human peripheral 
blood PMN were immunologically cross-reactive with 
the MPO isolated from the leukemic HL-60 cells. 
These results demonstrate hat, as with different 
formsof MPO in the mouse [8], there were differences 
in the sensitivity of the human MPOs to inhibition by 
AT. A similar difference has been reported between 2 
electrophoretically different forms of human MPO 
[7], and differences in the ability to oxidize halide 
ions was observed between chromatographically 
distinct murine forms of MPO [8]. This suggests hat 
there may be differences in the catalytic centers of 
these forms. MPO contains 2 heavy-light protomers 
joined along their long axes by a single disulfide bond 
between the heavy subunits [2 ,181. There are distinct 
differences in the patterns of purified MPO from 
peaks I-III when run on SDS-polyacrylamide gel 
electrophoresis under reducing conditions [191. More- 
over, there are significant differences in the amino 
acid composition between the different forms of 
MPO [19]; e.g., there is a progressive increase in the 
amount of arginine (I < II < III) while the ratio of 
aspartic acid to glutamic acid differs in a characteristic 
manner (III > I > II) [ 191. Further work on the 
chemical and enzymatic haracterization f each of 
the different forms of MPO and their respective sub- 
units should provide additional insight into the struc- 
ture-function relationships of this complex enzyme 
system. 
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